Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2.92M
-
Shares change
-
-1.5M
-
Total reported value, excl. options
-
$2.43M
-
Value change
-
-$1.66M
-
Put/Call ratio
-
1.06
-
Number of buys
-
8
-
Number of sells
-
-19
-
Price
-
$0.83
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q4 2021
42 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q4 2021.
Protalix BioTherapeutics, Inc. - COM (PLX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.92M shares
.
Largest 10 shareholders include MORGAN STANLEY (1.29M shares), GROUP ONE TRADING, L.P. (631K shares), Phoenix Holdings Ltd. (244K shares), Spire Wealth Management (126K shares), BlackRock Inc. (114K shares), TWO SIGMA ADVISERS, LP (99.9K shares), JANE STREET GROUP, LLC (85.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (82K shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (42.9K shares), and COMMONWEALTH EQUITY SERVICES, LLC (40.3K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.